These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 8853087)
1. Sympatholytic and minimum anesthetic concentration-sparing responses are preserved in rats rendered tolerant to the hypnotic and analgesic action of dexmedetomidine, a selective alpha(2)-adrenergic agonist. Rabin BC; Reid K; Guo TZ; Gustafsson E; Zhang C; Maze M Anesthesiology; 1996 Sep; 85(3):565-73. PubMed ID: 8853087 [TBL] [Abstract][Full Text] [Related]
2. Desensitization to the behavioral effects of alpha 2-adrenergic agonists in rats. Hayashi Y; Guo TZ; Maze M Anesthesiology; 1995 Apr; 82(4):954-62. PubMed ID: 7717568 [TBL] [Abstract][Full Text] [Related]
3. Role of pertussis toxin-sensitive G-proteins in the analgesic and anesthetic actions of alpha 2-adrenergic agonists in the rat. Hayashi Y; Rabin BC; Guo TZ; Maze M Anesthesiology; 1995 Oct; 83(4):816-22. PubMed ID: 7574062 [TBL] [Abstract][Full Text] [Related]
4. Chronic desipramine treatment desensitizes the rat to anesthetic and antinociceptive effects of the alpha2-adrenergic agonist dexmedetomidine. Guo TZ; Reid K; Davies MF; Nacif-Coelho C; Rabin BC; Gonzalez F; Maze M Anesthesiology; 1998 Jun; 88(6):1634-42. PubMed ID: 9637658 [TBL] [Abstract][Full Text] [Related]
5. Dissociation of hypnotic-anesthetic actions of alpha 2 agonists from cyclic AMP in the rat. Rabin BC; Guo TZ; Maze M Pharmacol Biochem Behav; 1997; 57(1-2):23-9. PubMed ID: 9164550 [TBL] [Abstract][Full Text] [Related]
6. Role of serotonergic neurotransmission in the hypnotic response to dexmedetomidine, an alpha 2-adrenoceptor agonist. Rabin BC; Guo TZ; Gregg K; Maze M Eur J Pharmacol; 1996 Jun; 306(1-3):51-9. PubMed ID: 8813614 [TBL] [Abstract][Full Text] [Related]
7. Hypnotic and analgesic effects of the alpha 2-adrenergic agonist dexmedetomidine in morphine-tolerant rats. Hayashi Y; Guo TZ; Maze M Anesth Analg; 1996 Sep; 83(3):606-10. PubMed ID: 8780290 [TBL] [Abstract][Full Text] [Related]
8. Chronic administration of an alpha 2 adrenergic agonist desensitizes rats to the anesthetic effects of dexmedetomidine. Reid K; Hayashi Y; Guo TZ; Correa-Sales C; Nacif-Coelho C; Maze M Pharmacol Biochem Behav; 1994 Jan; 47(1):171-5. PubMed ID: 7906889 [TBL] [Abstract][Full Text] [Related]
9. Perturbation of ion channel conductance alters the hypnotic response to the alpha 2-adrenergic agonist dexmedetomidine in the locus coeruleus of the rat. Nacif-Coelho C; Correa-Sales C; Chang LL; Maze M Anesthesiology; 1994 Dec; 81(6):1527-34. PubMed ID: 7992922 [TBL] [Abstract][Full Text] [Related]
10. The effect of imidazoline receptors and alpha2-adrenoceptors on the anesthetic requirement (MAC) for halothane in rats. Kagawa K; Mammoto T; Hayashi Y; Kamibayashi T; Mashimo T; Yoshiya I Anesthesiology; 1997 Oct; 87(4):963-7. PubMed ID: 9357900 [TBL] [Abstract][Full Text] [Related]
11. Pretreatment with dexmedetomidine: altered indices of anesthetic depth for halothane in the neuraxis of cats. Schmeling WT; Ganjoo P; Staunton M; Drexler C; Farber NE Anesth Analg; 1999 Mar; 88(3):625-32. PubMed ID: 10072018 [TBL] [Abstract][Full Text] [Related]
12. A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus coeruleus in rats. Correa-Sales C; Rabin BC; Maze M Anesthesiology; 1992 Jun; 76(6):948-52. PubMed ID: 1350889 [TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine produces a hypnotic-anesthetic action in rats via activation of central alpha-2 adrenoceptors. Doze VA; Chen BX; Maze M Anesthesiology; 1989 Jul; 71(1):75-9. PubMed ID: 2568769 [TBL] [Abstract][Full Text] [Related]
14. Sedative but not analgesic alpha2 agonist tolerance is blocked by NMDA receptor and nitric oxide synthase inhibitors. Davies MF; Reid K; Guo TZ; Agashe GS; Amin YK; Maze M Anesthesiology; 2001 Jul; 95(1):184-91. PubMed ID: 11465557 [TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine decreases halothane anesthetic requirements in rats. Segal IS; Vickery RG; Maze M Acta Vet Scand Suppl; 1989; 85():55-9. PubMed ID: 2571278 [TBL] [Abstract][Full Text] [Related]
16. Drugs acting at calcium channels can influence the hypnotic-anesthetic effect of dexmedetomidine. Horváth G; Kovács M; Szikszay M; Benedek G Acta Biochim Biophys Hung; 1991-1992; 26(1-4):75-81. PubMed ID: 1688240 [TBL] [Abstract][Full Text] [Related]
17. Pharmacologic characterization of the receptor mediating the hypnotic action of dexmedetomidine. Doze V; Chen BX; Li Z; Maze M Acta Vet Scand Suppl; 1989; 85():61-4. PubMed ID: 2571279 [TBL] [Abstract][Full Text] [Related]
18. [Adrenergic receptor and alpha 2 agonist--4: Applied and clinical pharmacology of alpha 2 agonist]. Mizobe T Masui; 1997 Aug; 46(8):1066-70. PubMed ID: 9283162 [TBL] [Abstract][Full Text] [Related]
19. Isoflurane but not halothane minimum alveolar concentration-sparing response of dexmedetomidine is enhanced in rats chronically treated with selective α2-adrenoceptor agonist. Santos M; Ibancovichi JA; Millán I; Tendillo FJ Lab Anim; 2012 Jul; 46(3):215-9. PubMed ID: 22522415 [TBL] [Abstract][Full Text] [Related]
20. Antisense technology reveals the alpha2A adrenoceptor to be the subtype mediating the hypnotic response to the highly selective agonist, dexmedetomidine, in the locus coeruleus of the rat. Mizobe T; Maghsoudi K; Sitwala K; Tianzhi G; Ou J; Maze M J Clin Invest; 1996 Sep; 98(5):1076-80. PubMed ID: 8787667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]